BACKGROUND: Fiberoptic bronchoscopy and lung biopsy are important diagnostic tools in patients with diffuse pulmonary infiltrates. However, these patients often have hypoxemic respiratory failure that makes this procedure hazardous. Noninvasive ventilation (NIV) has been shown to improve oxygenation in hypoxemic patients. OBJECTIVE: To report the efficacy and safety of an innovative technique of NIV-assisted bronchoscopic lung biopsy in a small case-series of hypoxemic subjects with diffuse parenchymal infiltrates; also to systematically review the literature on NIVassisted bronchoscopy. METHODS: Subjects with bilateral diffuse parenchymal infiltrates and P aO 2 /F IO 2 < 200 mm Hg underwent bronchoscopic lung biopsy under NIV support. NIV was initiated 10 min before the procedure and continued for 30 min after the procedure. The primary outcomes were performance of successful procedure and episodes of decline in S pO 2 < 90%. Secondary end points were the change in the respiratory and hemodynamic parameters during the procedure and occurrence of complications such as pneumothorax, hemorrhage, and endotracheal intubation. RESULTS: Six subjects, with a mean ؎ SD age of 44.5 ؎ 11.6 years, were included in the study. The median (interquartile range [IQR]) P aO 2 /F IO 2 prior to lung biopsy was 164.5 mm Hg (146.3-176.3 mm Hg), and the median (IQR) inspiratory and expiratory positive airway pressures were 14 cm H 2 O (12-15 cm H 2 O) and 5 cm H 2 O. Fiberoptic bronchoscopy was well tolerated and all subjects maintained S pO 2 > 92% during the procedure. One subject required endotracheal intubation due to hemoptysis. A definite diagnosis was obtained in 5 of the 6 subjects. A repeat procedure was performed in one subject, which again yielded no diagnosis. No other periprocedural complications were encountered. CONCLUSIONS: NIV-assisted bronchoscopic lung biopsy is a novel method for obtaining diagnosis in hypoxemic patients with diffuse lung infiltrates. However, this approach should be reserved for centers with extensive experience in NIV. More studies are required to define the utility of this approach.
Introduction
Fiberoptic bronchoscopy (FOB) is a valuable tool in evaluation of patients with diffuse pulmonary infiltrates. However, insertion of a flexible bronchoscope in the airway decreases the cross-sectional area proportional to the outer diameter of the flexible bronchoscope, and increases the resistance to air flow. 1 Usually inconsequential in patients without hypoxemia, a decrease in airway lumen size due to FOB can be detrimental in a hypoxemic patient, as it not only increases the work of breathing, but the P aO 2 also decreases by 10 -20 mm Hg after an uncomplicated bronchoscopy. 2 Furthermore, suction during bronchoscopy reduces the end-expiratory lung volume, which leads to alveolar closure and ventilation-perfusion mismatch. [1] [2] [3] Thus, supplemental oxygen is recommended during bronchoscopy in hypoxemic patients to achieve an S pO 2 of at least 90%. 4 Severe hypoxemia (P aO 2 Յ 60 mm Hg despite F IO 2 of 0.5) in non-intubated patients is generally regarded as a contraindication to bronchoscopy, as these patients are at high-risk for developing hypoxia-related cardiorespiratory complications. 5 Noninvasive ventilation (NIV) is the delivery of positive-pressure ventilation without an endotracheal airway. NIV is a safe and effective method of recruiting alveoli and augmenting ventilation, thereby ameliorating hypoxemia in patients with acute respiratory failure (ARF). 6 In fact, NIV used for pre-oxygenation is more effective at reducing arterial oxyhemoglobin desaturation than usual pre-oxygenation during endotracheal intubation in hypoxemic critically ill patients. 7 Several reports suggest that NIV can facilitate the performance of bronchoscopy in severely hypoxemic patients, by correcting the hypoxemia. However, all studies to date have used NIV for performance of bronchoalveolar lavage (BAL) in hypoxemic patients with pulmonary infiltrates. [8] [9] [10] [11] [12] [13] [14] [15] [16] No study has described the conduct of transbronchoscopic lung biopsy (TBLB) using NIV. We have wide experience with NIV and have found it suitable in correction of hypoxemia in diverse causes of respiratory failure. [17] [18] [19] [20] Herein, we describe the first report of NIV-assisted TBLB in a small case-series of 6 patients. We also review the literature on the use of bronchoscopy performed using NIV support.
Methods
All patients with diffuse pulmonary infiltrates and ARF requiring NIV assistance during TBLB were included in the study. The study was approved by the local ethics committee, and written informed consent was taken from all subjects. Patients were included in the study if they met all of the following criteria: diffuse pulmonary opacities on high-resolution computed tomography of the chest; negative results on sputum cytology and cultures requiring lung biopsy for further diagnosis; and severe hypoxemia, defined by P aO 2 /F IO 2 Ͻ 200 mm Hg on high-flow airentrainment mask. Patients were excluded from the study if any of the following was present: recent (Ͻ 1 month) acute myocardial infarction; platelet count Ͻ 75,000 cells/ L; coagulopathy, defined as prothrombin time or activated partial thromboplastin time Ͼ 1.5 times control; pH Ͻ 7.3 with P aCO 2 Ͼ 50 mm Hg; systolic blood pressure Ͻ 90 mm Hg or Ͼ 180 mm Hg; contraindication for NIV, including altered mental status, facial abnormality, or inability to fit the NIV mask.
Bronchoscopy Preparation
FOB was performed in the bronchoscopy suite by experienced faculty, using a wide channel videoscope (BF-1T 150, Olympus Optical, Tokyo, Japan). All subjects received nebulization with 4% lidocaine solution immediately before the procedure, and topical lidocaine jelly was applied in the nasal cavity. In addition, 2% lidocaine was instilled over the vocal cords, carina, and airways through the working channel of the flexible bronchoscope, to suppress cough during the procedure. No sedative was administered before or during the procedure.
NIV Protocol
NIV was delivered using a critical care ventilator (Servo-i, Maquet, Bridgewater, New Jersey) with an oronasal mask secured to the subject's face with elastic straps (Fig. 1) . NIV was initiated at F IO 2 of 1.0, starting 10 min before the procedure, and continued for 30 min after the procedure. Ventilatory parameters were set at a continuous positive airway pressure (CPAP) of 5 cm H 2 O and pressure support of 15 cm H 2 O, adjusted to maintain S pO 2 of Ͼ 92%. The bronchoscope was inserted through a dual axis swivel adapter attached to the mask, with the tight disposable cap of the swivel adapter preventing air leak during the procedure (see Fig. 1 ). Initially, the mask was removed from the face and the flexible bronchoscope was inserted through the mask and then through the nasal passage, to ensure quick access. Once the vocal cords were visible, the mask was again applied over the subject's face and connected to the ventilator, and the bronchoscopy procedure was continued. While performing lung biopsy, the CPAP was re-
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Current knowledge
Noninvasive ventilation (NIV) improves ventilation in hypercapnic respiratory failure and can improve oxygenation in select cases of hypoxemia. Fiberoptic bronchoscopy can be both an important diagnostic and therapeutic procedure in patients with respiratory disease. The use of bronchoscopic lung biopsy during NIV has not been studied systematically.
What this paper contributes to our knowledge
Bronchoscopic lung biopsy can be safely performed in patients with diffuse pulmonary infiltrates and acute respiratory failure receiving NIV. This approach should be performed only in centers with wide experience with both NIV and bronchoscopy.
duced to zero and only pressure support of 10 cm H 2 O was given. During bronchoscopy, F IO 2 was maintained at 1.0, and after bronchoscopy was decreased to the pre-bronchoscopy level. The positive-pressure ventilation was maintained for at least 30 min after the procedure, following which the subject was shifted back to oxygen therapy with air-entrainment mask. The application of NIV was extended if the S pO 2 could not be maintained to Ն 92% with air-entrainment mask.
Lung Biopsy
Bronchoscopy was performed in a standard fashion. The bronchoscope was wedged into the segmental bronchus of the desired biopsy site, determined from the radiologically abnormal areas on high-resolution computed tomography chest. Initially, BAL was performed with the tip of the bronchoscope wedged in the bronchial segment of interest, with sequential instillation of 20 mL saline aliquots. Subsequently, a conventional biopsy forceps (flexible bronchoscope 19C, Olympus Optical, Tokyo, Japan) was advanced through the working channel of the bronchoscope into the segmental bronchus until its tip was beyond bronchoscopic visualization. Once a gentle resistance was felt, the forceps was withdrawn by 1-2 cm proximally. The forceps was then opened and again advanced to the desired site and then closed and withdrawn while keeping the bronchoscope wedged in the same position. At least 4 biopsies were performed, unless there was any indication to terminate the procedure due to hypoxemia (S pO 2 Ͻ 90% on NIV) or bleeding.
Monitoring
We continuously monitored the S pO 2 and heart rate, while blood pressure was measured every 5 min during and 30 min after the procedure. An arterial blood gas analysis was performed before, during, and 15 min after the procedure. Chest radiograph and ultrasound examination were performed 2 hours after the procedure, to exclude pneumothorax. Facilities for endotracheal intubation and invasive ventilation were kept ready while performing the procedure.
End Points
The primary outcome was the performance of successful procedure, defined by completion of BAL and TBLB, and number of episodes of decline in S pO 2 to Ͻ 90%. Secondary end points were the change in the respiratory and hemodynamic parameters during the procedure and occurrence of complications like pneumothorax, hemorrhage, and endotracheal intubation.
Statistical Analysis
Data are presented in a descriptive fashion. The change in respiratory and hemodynamic variables over time were analyzed using the Friedman test.
Systematic Review
We first searched the literature for existing systematic reviews on NIV-assisted bronchoscopic biopsy. No reviews were found. Two authors (RA and AK) then independently searched the PubMed and EmBase databases for published papers reporting the use of NIV during bronchoscopy. We included relevant studies using the following free text terms: ("bronchoscopy" OR "fiberoptic bronchoscopy") AND ("niv" OR "noninvasive ventilation" OR "noninvasive ventilation" OR "nippv" OR "noninvasive positive-pressure ventilation" OR "noninvasive positivepressure ventilation" OR "cpap" OR "continuous positive airway pressure" OR "bipap" OR "bi-level positive airway pressure" OR "bi-level positive airway pressure" OR "positive pressure therapy" OR "nipsv" OR "noninvasive pressure support ventilation" OR "noninvasive pressure support ventilation" OR "mask ventilation" OR "nasal ventilation" OR "non invasive ventilation" OR "non invasive positive-pressure ventilation" OR "non invasive pressure support ventilation"). In addition we reviewed our personal files. We included studies describing the performance of NIV-assisted bronchoscopy in patients with ARF. We excluded single patient case-reports or studies involving Յ 5 patients.
Data were recorded on a standard data extraction form. The following items were extracted: publication details (title, authors, and other citation details), type of study (prospective or retrospective), demographic characteristics of the subjects, inclusion and exclusion criteria of individual studies, NIV settings and interface, bronchoscopy procedure and duration: diagnostic information from the bronchoscopy procedure, occurrence of hypoxemia (S pO 2 Ͻ 90%) during bronchoscopy, and endotracheal intubation related as a complication of the procedure (within 24 h of NIV-assisted bronchoscopy).
Results
Six subjects (3 males, 3 females) with a mean Ϯ SD age of 44.5 Ϯ 11.6 years were included in the study. All subjects were immunocompetent, except one, who was suffering from acquired immunodeficiency syndrome. The baseline characteristics of the subjects are shown in Table 1, and the representative computed tomography chest images of 2 subjects are shown in Figure 2 . All subjects had severe hypoxemia, with the median P aO 2 /F IO 2 being 164.5 mm Hg. Most of the subjects had chronic symptoms, with a median of 160 d (range 14 -240 d). The median (interquartile range) positive pressure used during bronchoscopy was 14 cm H 2 O (12-15 cm H 2 O)/5 cm H 2 O. Bronchoscopy was well tolerated, and the bronchoscopy procedure was successfully completed in all the subjects.
The changes in clinical and blood gas parameters are shown in Figure 3 . There was significant improvement in respiratory rate and P aO 2 /F IO 2 , and significant decline in heart rate after application of NIV, which was maintained throughout the procedure. All subjects maintained S pO 2 Ͼ 92% during the procedure. The actual bronchoscopy procedure, including BAL and TBLB, took a median of 11.5 min (range 8 -16 min). There was no evidence of pneumothorax on the post-procedure chest radiograph in any subject. One subject required elective endotracheal intubation following the procedure, due to hemoptysis. However, she did not require any additional blood transfusion and was extubated the same day. There was no mortality during the hospital stay.
A definite diagnosis was obtained in 5 (malignancy 2, lymphoma 1, sarcoidosis 1, pneumocystis pneumonia 1) of the 6 subjects with TBLB, while BAL was non-contributory in all these subjects. The results of TBLB enabled successful management of all subjects. A repeat procedure was performed in one subject, which again yielded no diagnosis. This subject was finally diagnosed as connective tissue disease-related non-specific interstitial pneumonia and started on glucocorticoid therapy.
Systematic Review of NIV-Assisted Bronchoscopy
Our initial search retrieved 113 citations, of which 20 studies involved NIV and bronchoscopy. Of these, 11 studies were further excluded as they were reviews, editorials, letters to the editor, or involved Ͻ 5 patients. Finally, 9 studies, involving 171 patients, were included for the systematic review. [8] [9] [10] [11] [12] [13] [14] [15] [16] All studies were prospective and observational, while 2 studies were randomized controlled trials (Table 2) . Except for one study that used CPAP alone, 10 all studies utilized NIV for ventilation during FOB. The characteristics of patients and procedures in various studies are shown in Tables 2 and 3 . All studies employed positive pressure therapy 10 -30 min prior to the procedure and continued NIV after the procedure for variable time periods. [8] [9] [10] [11] [12] [13] [14] [15] [16] 21 Seven studies used only topical anesthesia during bronchoscopy without any sedation or analgesia. [8] [9] [10] [11] [12] [13] [14] In one study, 15 additional intravenous midazolam and propofol boluses were administered for sedation, while in another study intravenous target controlled propofol infusion was used. 16 There was improvement in S pO 2 following the application of NIV during bronchoscopy in the majority of the studies. Only in the study by Chiner et al 12 did the S pO 2 decrease to 86 Ϯ 3% during FOB, while 3 patients in 2 other studies also developed hypoxemia during FOB. 13, 15 In contrast to all studies where NIV was used to facilitate FOB, Baumann et al performed FOB in critically ill patients who were already on NIV support for underlying illness and showed improvement in P aO 2 /F IO 2 while the F IO 2 was increased to 1.0 during the bronchoscopy procedure. 15 There were few complications. Of the 171 patients, 10 (5.8%) required endotracheal intubation related to the procedure (see Table 3 ). The diagnostic information obtained from bronchoscopy ranged from 60 -100%, with the pooled information rate (Fig. 4) across the studies being 79% (95% CI 65-90%).
Discussion
The results of our study suggest that NIV-assisted bronchoscopy is a safe and effective method of obtaining lung biopsy in hypoxemic patients with diffuse pulmonary disease. Several investigators have shown that bronchoscopy is associated with temporary alterations in gas exchange, hemodynamics, and lung mechanics, due to diminution in the airway size. [1] [2] [3] 22 The results of our study and the systematic review suggest that the use of NIV during bronchoscopy is associated with improvement in gas exchange, which can facilitate easy performance of BAL and lung biopsy.
In hypoxemic patients with diffuse pulmonary infiltrates, the options available include intubation and mechanical ventilation to ensure adequate ventilation during bronchoscopy, surgical lung biopsy, or institution of empirical treatment. Surgical lung biopsy allows direct sampling of lung tissue, with high sensitivity and specificity for the diag- Fig. 3 . Respiratory and hemodynamic parameters before, during, and after the procedure. There was substantial decline in respiratory rate and heart rate, and substantial improvement in P aO 2 /F IO 2 during and after the bronchoscopy procedure on NIV, compared to baseline. There was no important change in the mean arterial pressure nosis of diffuse lung processes. 23, 24 However, it is not readily available and there is often reluctance for this procedure in the ICU, both by the intensivists and the patients (or their relatives). An empiric treatment has been criticized due to the potential toxicities arising from unnecessary medical treatments, the excessive costs, and the risk of not treating an undiagnosed but reversible medical condition. 23, 25 Hence, there is a need for alternative strategies for obtaining lung biopsy in these critically ill patients, as many of these represent therapeutic emergencies. Our study suggests that NIV-assisted TBLB is another alternative in hypoxemic patients with diffuse pulmonary infiltrates. Several studies have reported the performance of NIVassisted bronchoscopy (see Tables 2 and 3 ). Antonelli et al were the first to report an NIV-assisted bronchoscopic procedure, when they performed BAL in 8 immunocompromised patients with severe hypoxemia (P aO 2 /F IO 2 Ͻ 100 mm Hg). The use of NIV was associated with significant improvements in P aO 2 /F IO 2 during bronchoscopy. 8 Da Conceicao et al investigated 10 consecutive COPD patients with pneumonia and ARF admitted to the ICU. During FOB with NIV, the S pO 2 increased from 91 Ϯ 4.7% at baseline to 97 Ϯ 1.7%. 9 In a randomized controlled trial of 30 patients with P aO 2 Ͻ 125 mm Hg despite high flow mask, Maitre et al showed significantly higher S pO 2 values in the CPAP group, compared to oxygen therapy alone, using a new CPAP device. Not only did the patients in the oxygen group develop hypoxemia during the bronchoscopy procedure, 5 patients in the oxygen group (compared to none in the CPAP group) required ventilatory assistance following the procedure. 10 Subsequently, in another randomized study involving 26 patients with nosocomial pneumonia and P aO 2 /F IO 2 Յ 200 mm Hg, Antonelli et al found the use of NIV superior to conventional oxygen supplementation, with better hemodynamic tolerance. 11 Application of NIV was associated with increase in P aO 2 /F IO 2 by 82%, in contrast to decline in P aO 2 / F IO 2 by 10% in the oxygen therapy group during FOB. Furthermore, the P aO 2 /F IO 2 remained elevated in the NIV group, while it fell by a further 10% 60 min post procedure in the oxygen therapy group. 11 The same group also found the helmet interface for delivering NIV to be safe in avoiding gas exchange deterioration. 21 Chiner et al evaluated nasal mask for delivering NIV while the FOB was performed orally using a bite block sealed with an elastic glove finger in 35 patients with a mean P aO 2 /F IO 2 of 168 mm Hg. In contrast to other studies, patients developed hypoxemia during the procedure, with S pO 2 decreasing to 86% during FOB. 12 Hence, this method cannot be routinely recommended for NIV-assisted FOB. Heunks et al reported the use of a novel full face mask for delivering positive pressure during diagnostic FOB in 12 patients with mean P aO 2 /F IO 2 of 192 mm Hg with hypoxemia. The procedure was successful in all patients, and in only one patient S pO 2 decreased to 86% during bronchoscopy. 13 In an interesting study, Scala et al showed that in patients with decompensated COPD with hypercapnic encephalopathy due to community-acquired pneumonia, and inability to clear copious secretions, the use of NIV with therapeutic bronchoscopy was associated with improvement in P aO 2 /F IO 2 of similar magnitude, compared to a control group of patients requiring invasive ventilation. Moreover, the occurrence of septic complications and tracheostomy was less in the NIV group, due to decrease in the rate of endotracheal intubation, albeit with similar hos- pital mortality, duration of ventilation, and hospital stay as in the invasive ventilation group. 14 All the previously mentioned studies have used NIV to prevent respiratory deterioration in spontaneously breathing hypoxemic patients undergoing bronchoscopy not otherwise requiring NIV for ARF. In contrast, Baumann et al reported the performance of FOB in patients with hypoxemic ARF requiring NIV for management. In 40 patients with mean Ϯ SD P aO 2 /F IO 2 of 176 Ϯ 54 mm Hg on NIV, bronchoscopy was successfully completed in all patients. Oxygen saturation fell below 90% in 2 patients, while 4 patients required endotracheal intubation following the procedure. 15 Our study is different from all the aforementioned studies in that it is the first study to report the performance of bronchoscopic lung biopsy under NIV support. In fact, need for TBLB has been considered as an exclusion criterion for NIV-assisted FOB. 10 Interestingly, BAL was non-contributory in all our subjects because, in contrast to the previous studies, which predominantly included subjects with suspected infection, the current study included predominantly non-infective subjects with relatively longer duration of hypoxia. This chronic nature of hypoxia might have also led them to tolerate higher levels of hypoxia and the conduct of the procedure. Although improvement with NIV was reassuring, more data are required in hypoxemic ARF of acute onset. In the majority of the studies, including our study, bronchoscopy was performed only with topical anesthesia, without any sedation or analgesia. However, Clouzeau et al performed FOB under NIV and propofol target-controlled infusion in hypoxemic patients, and found it not only to be safe but found it also to reduce patient discomfort. 16 Bronchoscopy in patients with ARF can be challenging, as it is associated with an alteration of the respiratory mechanics and gas exchange, with resultant hypoxemia, which could be detrimental in these patients. 1, 2 The causes of hypoxemia during bronchoscopy include ventilationperfusion mismatch from obstruction by the bronchoscope, frequent suctioning of the airways, and lavage fluid in the alveoli. The performance of BAL alone has been shown to worsen the P aO 2 during FOB. 1, 26 The current study and the systematic review of the literature suggest that FOB can be safely performed with NIV assistance in patients with ARF, with minimal complications. According to international consensus, NIV is defined as any form of ventilatory support applied without endotracheal intubation, and therefore includes CPAP as well. 27 The systematic review suggests that FOB can be safely performed with either CPAP 10 or NIV 11 assistance, depending on the availability, as no study has compared CPAP with NIV during bronchoscopy.
In our experience, the introduction of the bronchoscope into the nares through the face mask can be a difficult step, as the bronchoscope has to be considerably manipulated, which not only prolongs the procedure but can also cause trauma to the nasal mucosa. To facilitate easy passage, the bronchoscope is initially passed through the face mask, and the tip of bronchoscope is gently passed through the nose till the vocal cords are visible (see Fig. 1 ). The assistant then firmly secures the mask, avoiding substantial leakage. This simple modification facilitates quicker positioning of the bronchoscope. While performing lung biopsy, CPAP was reduced to zero and only pressure support was given in an attempt to avoid pneumothorax, and a similar approach has been used in intubated patients. 28 The rate of pneumothorax after TBLB in mechanically ventilated patients (14.3%) 28 is considerably higher than the reported frequency of 5% after TBLB in spontaneously breathing patients, 29, 30 and hence one needs to be ready to manage this complication.
Conclusions
In conclusion, FOB can be safely performed in patients with ARF under NIV support, and the results of this pilot study suggest that NIV-assisted TBLB can be considered as an alternative in patients in patients with ARF and diffuse pulmonary infiltrates. However, this approach should be performed only in centers with wide experience with both NIV and bronchoscopy. More studies are required to adequately define the utility of NIV-assisted bronchoscopic lung biopsy.
